Recombinant and Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non-Orthopedic Conditions (autologous PRP coverage)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines coverage and medical necessity for autologous platelet-rich plasma (PRP) used to treat wounds and other non-orthopedic conditions for Blue Cross Blue Shield - Rhode Island members, distinguishing Medicare Advantage from commercial products.
No material clinical or coverage changes in this revision.
Coverage Criteria
Coverage by Product Type
Coverage differs by product type:
Supported by CMS decision memo April 2021
Commercial product stance
For Commercial products, the use of autologous platelet-rich plasma (PRP) for the treatment of acute or chronic wounds — including surgical wounds and nonhealing ulcers — is considered not medically necessary due to insufficient evidence of clinical benefit. The policy specifically designates PRP for non-diabetic chronic wounds (HCPCS G0460) as not covered for Commercial members.
Use of platelet-rich plasma (autologous blood–derived preparations) for acute or chronic wounds in Commercial members is considered not medically necessary. This includes applications for surgical wounds and nonhealing ulcers and reflects the policy determination that available evidence is insufficient to show meaningful improvement in health outcomes.
If a service is determined to be not medically necessary (or is a medically necessary service that is a non‑covered benefit), providers may not bill the member for that service unless the member has been informed and has provided written agreement in advance to pay. Verify member benefits and follow the applicable participation and subscriber agreements before seeking member payment.
Coding and Billing
| G0465 | Autologous platelet rich plasma (PRP) for diabetic chronic wounds/ulcers, using an FDA-cleared device (includes administration, dressings, phlebotomy, centrifugation, and all other preparatory procedures, per treatment) |
| G0460 | Autologous platelet rich plasma for non-diabetic chronic wounds/ulcers, including phlebotomy, centrifugation, and all other preparatory procedures, administration and dressings, per treatment |
Provider Actions & Administrative Requirements
Prior authorization not required
Prior authorization is not applicable for autologous PRP under this policy.
Verify benefits and obtain authorizations if required
Verify member-specific benefits and obtain any required prior authorization per the member's benefit documents; contact the provider call center for member-specific information.
- Benefits and eligibility are determined by the member's subscriber agreement or member certificate and/or the employer agreement and those documents supersede this medical policy.
- For information on member-specific benefits, call the provider call center.
Check member Benefit Booklet / Evidence of Coverage
Benefits may vary among groups; refer to the member's Benefit Booklet, Evidence of Coverage, or Subscriber Agreement for plan-specific requirements.
Administrative and payer document guidance
Follow the member's subscriber agreement and employer agreement; this policy is informational and not a guarantee of payment.
- BCBSRI may revise this policy at any time; participation agreement provisions apply.
Use appropriate HCPCS code on claims
File claims with the HCPCS code that reflects the service and product: use G0465 when autologous PRP for diabetic chronic wounds is covered; G0460 describes PRP for non‑diabetic chronic wounds/ulcers.
- G0465 — Autologous platelet rich plasma for diabetic chronic wounds/ulcers (includes administration, dressings, phlebotomy, centrifugation, and all preparatory procedures), covered for Medicare Advantage when filed with a covered diagnosis.
- G0460 — Autologous platelet rich plasma for non‑diabetic chronic wounds/ulcers, described as not covered / not medically necessary for applicable products.
Benefit verification and informed written agreement required before billing member
Verify member benefits and eligibility with the provider call center and follow the member's subscriber agreement; obtain documented informed written member agreement before charging a member for services determined not medically necessary or non‑covered.
- Documentation of informed written member agreement is required before charging a member for services determined not medically necessary or non‑covered.
Commercial product denials for PRP in wounds
For Commercial Products, use of PRP for acute or chronic wounds is considered not medically necessary and claims will be denied.
- G0460 is identified for non‑diabetic chronic wounds/ulcers and is not covered for Medicare Advantage Plans and is not medically necessary for Commercial Products.
Risk of member billing only with prior written agreement
If services are determined to be not medically necessary or are non‑covered benefits, providers may not charge the member unless the member has been informed and has given advance written agreement to pay.
- Follow your participation agreement(s) for applicable provisions.
- Call the provider call center for member‑specific benefit information before obtaining member agreement.
Background
Autologous platelet‑rich plasma (PRP) is an autologous platelet concentrate suspended in plasma and prepared from centrifuged autologous blood. PRP is activated (for example, with thrombin and calcium) to release growth factors such as PDGF, TGF and VEGF and can form a platelet gel that is applied topically to wounds or used adjunctively in surgical procedures. It is distinct from fibrin sealants, which are derived from platelet‑poor plasma and consist primarily of fibrinogen.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.